Hoya Vision Canada is proud to announce the appointment of Christine Le Brasseur, Dispensing Optician for eight years, as Territory Manager for the eastern part of Montreal as well as the North shore.
She will be visiting independent clinics and presentingto Eye Care Practitioners all the advantages that Hoya Vision offers as a strategic alliance.
VuePoint wants to express their solidarity with the French people and sympathy to the families of the victims of these deadly terrorist attacks committed Friday November 13th.
La Dolce Vita sunglasses and optical eyewear draw their inspiration from Italy’s particular version of the ‘swinging sixties’. Enthusiasm, beauty, creativity and art are the keywords of the collection. This eyewear range is available in acetate with a special velvet-effect finish that is hand-crafted in Italy.
Attention to detail defines the 12 optical frames and 4 sunglasses (2 for women and 2 for men). The acetate sun and optical collection (Mazzucchelli) is made up of items of vintage inspiration, with a predominance of rounded shapes.
The coming season’s novelties include an elegant new personality-packed model for the Velluto Collection in red or teal.
Research published on November 5 in the journal Science could lead to eye drops that restore transparency to lenses clouded by cataracts using a newly discovered chemical compound.
The American research team’s study began with 2,450 compounds and was eventually narrowed down to 32 chemicals based on lanosterol, which was shown to have cataract reversing properties, though lanosterol’s poor solubility required it to be injected directly into the lens.
One of these chemicals, referred to as “compound 29”, was settled on as the most likely candidate. Compound 29 was soluble enough to be delivered in eye drops, and was able to bind to the crystallins in the lens and break up the insoluble clumps of proteins causing clouding.
In vivo tests on mice showed that eye drops containing compound 29 restored transparency to lenses affected by cataracts, as did ex vivo tests on human lens tissue, though study lead Jason Gestwicki cautions that transparency measurements are not a direct measurement of visual acuity.
Viewpoint Therapeutics, founded by study co-author Leah Makley, is developing compound 29 for human use as a cataract treatment.
Further information: https://www.ucsf.edu/news/2015/11/176886/eye-drops-could-clear-cataracts-using-newly-identified-chemical
Alternative & Plan B Eyewear have become the new Canadian distributors for ThinOptics, a revolutionary new product that will ensure you always have your reading glasses with you! These frames weigh less than a nickel and are made from shatter-proof polycarbonate, the same material used for high-end prescription lenses. Comfortable and stable nose-pads ensure a universal fit for all face shapes. Featuring flex-grip technology with a titanium bridge, they are 10x more elastic than spring steel and guaranteed to hold up against wear and tear.
AYA Optical brings together Indigenous art and contemporary eyewear design, creating frames that honour artists while offering a distinctive and meaningful visual identity.
Learn More
The Vision Council Foundation has expanded its See What Matters initiative with new back to school toolkits focused on childhood myopia, digital eye strain and the importance of annual eye exams.
Read more
Bausch + Lomb is advancing two first in class therapies following new clinical results, including a Phase 3 dry eye combination treatment and a TRPV1 antagonist showing early pain reduction.
Read more
SILMO Paris returns 25–28 September, bringing together global eyewear and optical professionals for four days of innovation, trends, conferences and industry dialogue.
Read more
SDC Technologies has expanded its investment in flō Optics and will join the company’s Board, strengthening their strategic partnership and supporting commercialization of digital coating technologies.
Read more
AYA Optical brings together Indigenous art and contemporary eyewear design, creating frames that honour artists while offering a distinctive and meaningful visual identity.
Learn More The Vision Council Foundation has expanded its See What Matters initiative with new back to school toolkits focused on childhood myopia, digital eye strain and the importance of annual eye exams.
Read More Bausch + Lomb is advancing two first in class therapies following new clinical results, including a Phase 3 dry eye combination treatment and a TRPV1 antagonist showing early pain reduction.
Read More SILMO Paris returns 25–28 September, bringing together global eyewear and optical professionals for four days of innovation, trends, conferences and industry dialogue.
Read More SDC Technologies has expanded its investment in flō Optics and will join the company’s Board, strengthening their strategic partnership and supporting commercialization of digital coating technologies.
Read More
AYA Optical brings together Indigenous art and contemporary eyewear design, creating frames that honour artists while offering a distinctive and meaningful visual identity.
Learn More The Vision Council Foundation has expanded its See What Matters initiative with new back to school toolkits focused on childhood myopia, digital eye strain and the importance of annual eye exams.
Read more Bausch + Lomb is advancing two first in class therapies following new clinical results, including a Phase 3 dry eye combination treatment and a TRPV1 antagonist showing early pain reduction.
Read more SILMO Paris returns 25–28 September, bringing together global eyewear and optical professionals for four days of innovation, trends, conferences and industry dialogue.
Read more SDC Technologies has expanded its investment in flō Optics and will join the company’s Board, strengthening their strategic partnership and supporting commercialization of digital coating technologies.
Read more AYA Optical brings together Indigenous art and contemporary eyewear design, creating frames that honour artists while offering a distinctive and meaningful visual identity.
Learn More The Vision Council Foundation has expanded its See What Matters initiative with new back to school toolkits focused on childhood myopia, digital eye strain and the importance of annual eye exams.
Read more Bausch + Lomb is advancing two first in class therapies following new clinical results, including a Phase 3 dry eye combination treatment and a TRPV1 antagonist showing early pain reduction.
Read more SILMO Paris returns 25–28 September, bringing together global eyewear and optical professionals for four days of innovation, trends, conferences and industry dialogue.
Read more SDC Technologies has expanded its investment in flō Optics and will join the company’s Board, strengthening their strategic partnership and supporting commercialization of digital coating technologies.
Read more
